• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-34a通过调节肿瘤坏死因子α(TNFα)的表达抑制自噬,从而保护心肌细胞免受缺血-再灌注损伤。

MicroRNA-34a protects myocardial cells against ischemia-reperfusion injury through inhibiting autophagy via regulating TNFα expression.

作者信息

Shao Haifeng, Yang Lili, Wang Li, Tang Bozan, Wang Jian, Li Qiang

机构信息

Department of Cardiology, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar 161000, China.

出版信息

Biochem Cell Biol. 2018 Jun;96(3):349-354. doi: 10.1139/bcb-2016-0158. Epub 2017 May 25.

DOI:10.1139/bcb-2016-0158
PMID:28544853
Abstract

BACKGROUND

ischemia-reperfusion (I/R) is a consequence of restored blood supply after myocardial infarction. Myocardial I/R injury can be alleviated by reducing autophagy in heart tissue. MicroRNA-34a (miR-34a) has been shown to regulate autophagy in a renal model of I/R, but it is not known whether it can protect cardiac tissues from I/R injury. This study investigated how miR-34a protects myocardial cells from I/R injury by inhibiting autophagy via regulation of tumor necrosis factor α (TNFα).

METHODS

we constructed an I/R model in vivo using Langendorff perfusion, and we constructed an in vivo model by treating neonatal rat cardiomyocytes (NRCMs) with hypoxia-reoxygenation (H/R method). Transfected adenoviral-overexpressed miR-34a mimics and controlled NRCMs after H/R. We analyzed cell viability using the MTT assay and a cell counting kit-8 (CCK-8) assay. Changes in the rate of apoptosis were detected by flow cytometry. We investigated the effect mechanisms of miR-34a with Western blot and luciferase assays.

RESULTS

miR-34a expression decreased after in vivo reperfusion of the myocardial cells and heart tissues of neonatal rats. MiR-34a reduced apoptosis of the NRCMs and autophagy levels, simultaneously, after H/R injury. Further, miR-34a decreased the expression of Lc3-II and p62, indicating that miR-34a reduces myocardial I/R injury by decreasing TNFα expression.

CONCLUSION

miR-34a can inhibit autophagy levels after I/R by targeting TNFα, thereby reducing myocardial injury.

摘要

背景

缺血再灌注(I/R)是心肌梗死后恢复血液供应的结果。心肌I/R损伤可通过减少心脏组织中的自噬来缓解。微小RNA-34a(miR-34a)已被证明在I/R的肾脏模型中调节自噬,但尚不清楚它是否能保护心脏组织免受I/R损伤。本研究调查了miR-34a如何通过调节肿瘤坏死因子α(TNFα)抑制自噬来保护心肌细胞免受I/R损伤。

方法

我们使用Langendorff灌注在体内构建I/R模型,并通过用缺氧复氧(H/R方法)处理新生大鼠心肌细胞(NRCMs)构建体内模型。在H/R后转染腺病毒过表达的miR-34a模拟物并对照NRCMs。我们使用MTT法和细胞计数试剂盒-8(CCK-8)法分析细胞活力。通过流式细胞术检测凋亡率的变化。我们用蛋白质印迹法和荧光素酶测定法研究miR-34a的作用机制。

结果

新生大鼠心肌细胞和心脏组织在体内再灌注后miR-34a表达降低。在H/R损伤后,miR-34a同时降低了NRCMs的凋亡和自噬水平。此外,miR-34a降低了Lc3-II和p62的表达,表明miR-34a通过降低TNFα表达来减少心肌I/R损伤。

结论

miR-34a可通过靶向TNFα抑制I/R后的自噬水平,从而减少心肌损伤。

相似文献

1
MicroRNA-34a protects myocardial cells against ischemia-reperfusion injury through inhibiting autophagy via regulating TNFα expression.微小RNA-34a通过调节肿瘤坏死因子α(TNFα)的表达抑制自噬,从而保护心肌细胞免受缺血-再灌注损伤。
Biochem Cell Biol. 2018 Jun;96(3):349-354. doi: 10.1139/bcb-2016-0158. Epub 2017 May 25.
2
Inhibition of miR-34a-5p protected myocardial ischemia reperfusion injury-induced apoptosis and reactive oxygen species accumulation through regulation of Notch Receptor 1 signaling.miR-34a-5p 的抑制通过调节 Notch 受体 1 信号通路保护心肌缺血再灌注损伤诱导的细胞凋亡和活性氧积累。
Rev Cardiovasc Med. 2019 Sep 30;20(3):187-197. doi: 10.31083/j.rcm.2019.03.545.
3
Upregulation of microRNA-34a enhances myocardial ischemia-reperfusion injury via the mitochondrial apoptotic pathway.miR-34a 的上调通过线粒体凋亡途径增强心肌缺血再灌注损伤。
Free Radic Res. 2022 Mar-Apr;56(3-4):229-244. doi: 10.1080/10715762.2021.1953004. Epub 2022 Jun 15.
4
MiR-324/SOCS3 Axis Protects Against Hypoxia/Reoxygenation-Induced Cardiomyocyte Injury and Regulates Myocardial Ischemia via TNF/NF-κB Signaling Pathway.微小RNA-324/细胞因子信号转导抑制因子3轴通过肿瘤坏死因子/核因子-κB信号通路预防缺氧/复氧诱导的心肌细胞损伤并调节心肌缺血。
Int Heart J. 2020 Nov 28;61(6):1258-1269. doi: 10.1536/ihj.19-687. Epub 2020 Nov 13.
5
Suppression of miR-34a Expression in the Myocardium Protects Against Ischemia-Reperfusion Injury Through SIRT1 Protective Pathway.心肌中miR-34a表达的抑制通过SIRT1保护途径预防缺血再灌注损伤。
Stem Cells Dev. 2017 Sep 1;26(17):1270-1282. doi: 10.1089/scd.2017.0062. Epub 2017 Jul 20.
6
Knockdown of lncRNA AK139328 alleviates myocardial ischaemia/reperfusion injury in diabetic mice via modulating miR-204-3p and inhibiting autophagy.敲低长非编码 RNA AK139328 通过调节 miR-204-3p 抑制自噬减轻糖尿病小鼠心肌缺血/再灌注损伤。
J Cell Mol Med. 2018 Oct;22(10):4886-4898. doi: 10.1111/jcmm.13754. Epub 2018 Jul 25.
7
MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1.miR-223 通过靶向 PARP-1 保护新生大鼠心肌细胞和 H9c2 细胞免于缺氧诱导的凋亡和过度自噬,通过 Akt/mTOR 通路。
J Mol Cell Cardiol. 2018 May;118:133-146. doi: 10.1016/j.yjmcc.2018.03.018. Epub 2018 Mar 31.
8
Overexpression of miR-638 attenuated the effects of hypoxia/reoxygenation treatment on cell viability, cell apoptosis and autophagy by targeting ATG5 in the human cardiomyocytes.miR-638 的过表达通过靶向 ATG5 减弱了低氧/复氧处理对人心肌细胞活力、细胞凋亡和自噬的影响。
Eur Rev Med Pharmacol Sci. 2018 Dec;22(23):8462-8471. doi: 10.26355/eurrev_201812_16546.
9
MicroRNA-449a Inhibition Protects H9C2 Cells Against Hypoxia/Reoxygenation-Induced Injury by Targeting the Notch-1 Signaling Pathway.微小RNA-449a抑制通过靶向Notch-1信号通路保护H9C2细胞免受缺氧/复氧诱导的损伤。
Cell Physiol Biochem. 2018;46(6):2587-2600. doi: 10.1159/000489686. Epub 2018 May 7.
10
MicroRNA-204 protects H9C2 cells against hypoxia/reoxygenation-induced injury through regulating SIRT1-mediated autophagy.微小 RNA-204 通过调节 SIRT1 介导的自噬来保护 H9C2 细胞免受缺氧/复氧诱导的损伤。
Biomed Pharmacother. 2018 Apr;100:15-19. doi: 10.1016/j.biopha.2018.01.165. Epub 2018 Feb 6.

引用本文的文献

1
Comprehensive evaluation of non-coding RNA-mediated autophagy regulation in myocardial ischemia-reperfusion injury.非编码RNA介导的自噬调控在心肌缺血再灌注损伤中的综合评价
Front Pharmacol. 2025 Apr 25;16:1581341. doi: 10.3389/fphar.2025.1581341. eCollection 2025.
2
Regulation of autophagy of the heart in ischemia and reperfusion.缺血再灌注时心脏自噬的调节
Apoptosis. 2023 Feb;28(1-2):55-80. doi: 10.1007/s10495-022-01786-1. Epub 2022 Nov 11.
3
Leptin relieves ischemia/reperfusion induced acute kidney injury through inhibiting apoptosis and autophagy.
瘦素通过抑制细胞凋亡和自噬缓解缺血再灌注引起的急性肾损伤。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2022 Jan 28;47(1):8-17. doi: 10.11817/j.issn.1672-7347.2022.210244.
4
The Regulatory Role of Non-coding RNA in Autophagy in Myocardial Ischemia-Reperfusion Injury.非编码RNA在心肌缺血再灌注损伤自噬中的调控作用
Front Pharmacol. 2022 Mar 17;13:822669. doi: 10.3389/fphar.2022.822669. eCollection 2022.
5
Functional Role of microRNAs in Regulating Cardiomyocyte Death.microRNAs 在调控心肌细胞死亡中的功能作用。
Cells. 2022 Mar 12;11(6):983. doi: 10.3390/cells11060983.
6
Cordycepin alleviates myocardial ischemia/reperfusion injury by enhancing autophagy via AMPK-mTOR pathway.虫草素通过 AMPK-mTOR 通路增强自噬来减轻心肌缺血/再灌注损伤。
J Physiol Biochem. 2022 May;78(2):401-413. doi: 10.1007/s13105-021-00816-x. Epub 2022 Mar 1.
7
Targeting the microRNA-34a as a Novel Therapeutic Strategy for Cardiovascular Diseases.靶向微小RNA-34a作为心血管疾病的一种新型治疗策略。
Front Cardiovasc Med. 2022 Jan 27;8:784044. doi: 10.3389/fcvm.2021.784044. eCollection 2021.
8
Exosomes and Micro-RNAs in Aging Process.衰老过程中的外泌体与微小RNA
Biomedicines. 2021 Aug 6;9(8):968. doi: 10.3390/biomedicines9080968.
9
LncRNAs Participate in Post-Resuscitation Myocardial Dysfunction Through the PI3K/Akt Signaling Pathway in a Rat Model of Cardiac Arrest and Cardiopulmonary Resuscitation.在心脏骤停与心肺复苏大鼠模型中,长链非编码RNA通过PI3K/Akt信号通路参与复苏后心肌功能障碍。
Front Physiol. 2021 Jun 14;12:689531. doi: 10.3389/fphys.2021.689531. eCollection 2021.
10
Resveratrol Pretreatment Improved Heart Recovery Ability of Hyperglycemic Bone Marrow Stem Cells Transplantation in Diabetic Myocardial Infarction by Down-Regulating MicroRNA-34a.白藜芦醇预处理通过下调微小RNA-34a改善糖尿病心肌梗死中高血糖骨髓干细胞移植的心脏恢复能力。
Front Pharmacol. 2021 Apr 20;12:632375. doi: 10.3389/fphar.2021.632375. eCollection 2021.